Mode
Text Size
Log in / Sign up

Diabetes prevalence 22% in Ghanaian TB cohort, associated with older age and higher BMIA Hidden Health Link Doctors Are Now Spotting in Tuberculosis Patients

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider diabetes screening in TB patients, noting association with older age and higher BMI in this cohort.

A prospective cohort study followed 204 adults (≥20 years) with bacteriologically confirmed pulmonary tuberculosis across 14 health facilities in Greater Accra, Ghana. Participants with diabetes (the exposure) were compared to those with tuberculosis only. The study aimed to assess the association between diabetes and tuberculosis clinical presentation and treatment outcomes.

Among the 204 participants, 45 (22.1%) had diabetes at baseline; 30 of these were newly diagnosed. Diabetes was significantly associated with being age 60 or older (adjusted odds ratio [AOR] 5.7, 95% CI 1.7–19.3), having a BMI of 25 kg/m² or higher (AOR 5.4, 95% CI 1.4–21.9), and having a family history of diabetes (AOR 3.7, 95% CI 1.5–9.4). Cavities on chest X-ray were less frequent in the tuberculosis-diabetes group (51.2%) than in the tuberculosis-only group (72.5%; P = 0.014).

Overall favorable tuberculosis treatment outcomes were reported in 90.7% of participants. Unfavorable outcomes occurred in 6.8% of the tuberculosis-diabetes group versus 10.1% of the tuberculosis-only group (relative risk 0.68, 95% CI 0.2–2.2), a difference that was not statistically significant. Safety and tolerability data were not reported.

Key limitations include the observational design, which cannot prove causation, and the fact that results come from a single cohort. The confidence interval for the association between diabetes and unfavorable treatment outcomes was wide and included 1.0, indicating statistical uncertainty. The study's practice relevance is restrained; it supports existing recommendations for routine diabetes screening in tuberculosis patients for early detection and management, but the clinical implications of the radiographic finding and non-significant outcome difference remain unclear.

Tuberculosis remains a major global health threat. It is a bacterial infection that primarily attacks the lungs. Treatment involves a long course of antibiotics.

Diabetes is a chronic condition where the body struggles to manage blood sugar levels. When these two diseases meet, they create a dangerous duo. This combination, called TB-diabetes, is a growing concern worldwide.

Managing one complex illness is hard enough. Managing two at once is a tremendous challenge for patients and doctors. The big problem has been that the diabetes often goes unseen.

The Surprising Shift

For years, the medical focus has been on how diabetes might make TB worse. The assumption was that having both would lead to poorer recovery from TB.

But here's the twist.

This new study suggests the outcomes can be similar. However, it uncovers something more urgent: diabetes is hiding in plain sight among TB patients.

A Silent Partner in the Lungs

Think of your immune system as the body's security team. Diabetes can weaken this team. This might make it easier for TB to take hold in the first place.

Once TB is active, high blood sugar from diabetes can create an environment where bacteria thrive. It's like adding fuel to a fire.

Interestingly, the study found one key difference in how TB appears. People with both conditions had fewer cavities in their lungs on X-rays than those with only TB. Cavities are holes created by severe infection.

This is a clue that the diseases interact in complex ways we are still learning about.

Researchers in Ghana followed 204 adults starting treatment for confirmed lung TB. They screened everyone for diabetes at the start using blood tests. They then tracked their TB treatment results over time.

The goal was simple: see how common diabetes is, and if it changed how people fared.

The first result was striking. Over 22% of the TB patients had diabetes. That's more than one in every five people.

Even more telling, two-thirds of those with diabetes were learning about it for the very first time during their TB screening. Their diabetes was a hidden condition.

The study also identified who was most at risk. TB patients who were older, had a higher body weight, or had a family history of diabetes were significantly more likely to have this dual diagnosis.

Now, for the treatment outcomes. The vast majority of patients, over 90%, had a successful recovery. The rate of unsuccessful treatment was slightly lower in the TB-diabetes group compared to the TB-only group, but the difference was not statistically significant.

This is where the story gets crucial.

The similar outcomes are good news. But they do NOT mean diabetes is harmless in TB. Instead, they highlight the success of integrated care when the diabetes is found and managed.

The study strongly supports a call to action that global health experts have been making. The World Health Organization already recommends checking TB patients for diabetes. This research provides clear, local evidence for why this practice is so vital.

It shifts the focus from fearing worse outcomes to emphasizing the power of early detection.

If you or a loved one is being treated for tuberculosis, this research underscores a simple, important step.

Ask your doctor about screening for diabetes. A straightforward blood test can check your blood sugar levels. This is especially important if you have risk factors like being over 40, having a family history of diabetes, or having a higher body weight.

Finding and managing diabetes early can protect your overall health during and after TB treatment.

The Important Limitations

This study was conducted in one region of Ghana. The findings are powerful for that setting and highlight a global issue. However, exact percentages may differ in other parts of the world.

The study also shows a link, not direct cause and effect. More research will help us fully understand the biological dance between these two diseases.

The path forward is clear and actionable. The study adds to the loud call for routine, universal diabetes screening in all TB clinics. This is not a distant future technology. It is a practical tool available now.

The goal is to make "dual screening" standard. Just as we check for TB, we should check for diabetes. By catching the hidden condition, doctors can create a combined treatment plan. This gives every patient the best shot at a full recovery from both.

Building this system requires training and resources. But the evidence, like that from this Ghanaian study, makes a compelling case. It shows that looking for the hidden link is one of the smartest things we can do in the fight against TB.

Study Details

Study typeCohort
EvidenceLevel 3
PublishedApr 2026
View Original Abstract ↓
BackgroundTuberculosis (TB)-diabetes is a growing public health threat in TB-endemic settings. We aimed to determine diabetes prevalence among TB patients in Greater Accra and its association with TB clinical presentation and treatment outcomes.MethodsWe enrolled 204 adults (≥20 years) with bacteriologically confirmed pulmonary TB across 14 health facilities. At treatment initiation, participants were screened for diabetes using self-report, fasting plasma glucose, and glycated hemoglobin, following standard diagnostic criteria. Baseline characteristics were recorded, and participants were followed to determine TB treatment outcomes. Associations between diabetes, baseline characteristics and treatment outcomes were assessed using bivariate and multivariate analysis in STATA. Adjusted odds ratios (AORs) and risk ratios (RRs) were estimated with 95% confidence intervals (CIs).ResultsThe median age of participants was 40.5 years (IQR 30.5–50.5), and 72.5% were male. The prevalence of baseline diabetes was 22.1% (45/204), including 30 newly diagnosed and 15 previously diagnosed participants on treatment. Among 166 chest X-rays, cavities were less frequent in TB-diabetes than TB-only participants (51.2% vs. 72.5%, P = 0.014). Diabetes was associated with age ≥60 years (AOR 5.7, 95% CI 1.7–19.3), body mass index ≥25 kg/m2 (AOR 5.4, 95% CI 1.4–21.9), and family history of diabetes (AOR 3.7, 95% CI 1.5–9.4). Overall, 90.7% had favorable TB treatment outcomes, with unfavorable outcomes in 6.8% of TB-diabetes and 10.1% of TB-only participants (RR 0.68, 95% CI 0.2–2.2).ConclusionDiabetes was common among TB patients, with many previously undiagnosed. Despite similar treatment outcomes to TB-only participants, routine diabetes screening is recommended for early detection and management.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.